General procedure for the preparation of the 1,5-benzodiazepinium picrates. Solutions of 1.0 mmol
of the diaminobenzene derivatives in 20 mL of ethanol were treated with pentane-2,4-dione (0.1 g; 1.0
mmol), and 0.5 g of picric acid (50% water). The reactions started immediately whereupon the color
changed to dark violet. The mixtures were stirred for 30 min at rt. By addition of ether the precipitation of
the solids was completed. The compounds were filtered off and washed with ether to give intensely violet
fine analytically pure solids.
6-Hydroxy-2,4-dimethyl-5H-benzo[b][1,4]diazepin-1-ium picrate (7a).
2,3-Diaminophenol (0.372 g, 3.0 mmol) was used, yield 0.75 g (61%), mp 198-200 °C; H NMR
1
(DMSO-d6) δ = 10.70 (s, 1H), 9.55 (s, 1H), 9.07 (s, 1H), 8.60 (s, 2H), 6.78 (d, J = 8.15 Hz, 1H), 6.51 (dd,
J = 8.15/7.83 Hz, 1H), 5.96 (d, J = 7.83 Hz, 1H), 4.30 (s, 1H), 1.89 (s, 3H), 1.80 (s, 3H); 13C NMR
(DMSO-d6): δ = 24.1, 24.2, 95.7, 113.8, 116.2 , 120.2, 124.1, 125.2, 129.8, 136.1, 141.8, 149.9, 160.8,
175.1, 176.5; IR (KBr) 3313, 3083, 1609, 1566, 1542, 1429 cm-1; UV λmax(H2O) 218, 256, 358 nm;
λ
max(MeOH) 356, 590 nm; λmax(EtOH) 258, 360 nm; MS m/z (rel. int.) 188 (M+-1, 100), 173(33), 148(29),
91(46), 77(29), 62(85), 52(64); Anal. Calcd for C17H15N5O8: C, 48.93; H, 3.62; N, 16.78. Found: C,
48.97; H, 3.53; N, 16.87.
7-Hydroxy-2,4-dimethyl-5H-benzo[b][1,4]diazepin-1-ium picrate (7b).
3,4-Diaminophenol (0.248 g, 2.0 mmol) was used, yield 0.59 g (71%), mp 228-230 °C; H NMR
1
(DMSO-d6) δ = 9.97 (s, 1H), 9.78 (s, 1H), 9.09 (s, 1H), 8.60 (s, 2H), 6.29 (d, J = 8.59 Hz, 1H), 6.18 (dd, J
= 8.59/2.40 Hz, 1H), 5.92 (d, J = 2.40 Hz, 1H), 4.06 (s, 1H), 1.73 (s, 3H), 1.70 (s, 3H); 13C NMR
(DMSO-d6): δ = 23.7, 23.8, 94.2, 110.7, 113.0, 123.5, 124.1, 125.2, 135.2, 141.8, 158.3, 160.7, 172.6,
173.6; IR (KBr) 3424, 3306, 3080, 1612, 1541, 1480, 1432 cm-1; UV λmax(H2O) 204, 262, 352 nm;
λ
max(MeOH) 284, 348 nm; λmax(EtOH) 268, 286, 354 nm; MS m/z (rel. int.) 188 (M+-1, 100), 173 (10),
146 (23), 106 (7), 77 (88), 5 (11); Anal. Calcd for C17H15N5O8: C, 48.93; H, 3.62; N, 16.78. Found: C,
48.65; H, 3.79; N, 16.78.
7-Methoxy-2,4-dimethyl-5H-benzo[b][1,4]diazepin-1-ium picrate (7c).
4-Methoxy-1,2-diaminobenzene dihydrochloride (1.056 g, 5.0 mmol) was used, yield : 1.83 g (86%), mp
210-212 °C; 1H NMR (DMSO-d6): δ = 9.83 (s, 1H), 9.20 (s, 1H), 8.61 (s, 2H), 6.39 (d, J = 1.26 Hz, 2H),
6.02 (m, 1H), 4.09 (s, 1H), 3.64 (s, 3H), 1.75 (s, 3H), 1.71 (s, 3H); 13C NMR (DMSO-d6): δ = 24.5, 24.6,
56.2, 95.3, 110.8, 111.6 , 124.9, 125.7, 125.9, 126.0, 136.0, 142.5, 160.4, 161.5, 173.6, 174.7; IR (KBr)
3321, 1630, 1609, 1559, 1521, 1481, 1365 cm-1; UV λmax(H2O) 214, 264, 350 nm; λmax(MeOH) 350, 524
nm; λmax(EtOH) 266, 284, 358 nm; MS m/z (rel. int.) 202(M+-1, 100), 187(54), 159(10), 147(18), 118(11),
91(13), 77(7), 62(7); Anal. Calcd for C18H17N5O8: C, 50.12; H, 3.97; N, 16.24. Found: C, 50.15; H, 3.92;
N, 15.93.
7-Carboxy-2,4-dimethyl-5H-benzo[b][1,4]diazepin-1-ium picrate (7d).
3,4-Diaminobenzoic acid (1.52 g, 10.0 mmol) was used, yield 3.87 g (88%), mp 205-207 °C; H NMR
1
(DMSO-d6): δ = 13.15 (br s, 1H), 9.85 (s, 1H), 9.63 (s, 1H), 8.61 (s, 1H), 8.60 (s, 1H), 7.40 (d, J = 8.14
Hz, 1H), 6.99 (s, 1H), 6.48 (d, J = 8.14 Hz, 1H), 4.23 (s, 1H), 1.77 (s, 3H), 1.75 (s, 3H); 13C NMR
(DMSO-d6): δ = 24.1, 96.1, 96.2, 123.1, 124.0, 124.1, 125.2, 130.6, 133.5, 133.5, 138.2, 141.8, 165.1,
175.3, 176.5; IR (KBr) 3310, 3071, 3003, 1692, 1631, 1600, 1568, 1554, 1520, 1435 cm-1; UV λmax(H2O)
268, 354 nm; λmax(MeOH) 352, 524 nm; λmax(EtOH) 242, 270, 360 nm; MS m/z (rel. int.) 216(M+-1, 100),
199(16), 171(21), 159(13), 130(29), 103(13), 91(31), 77(28), 63(52), 53(29); Anal. Calcd for
C18H15N5O9: C, 48.55; H, 3.39; N, 15.73. Found: C, 48.56; H, 3.40; N, 15.41.